FAJJ Med: what changed
Two financial years side by side, explained: what moved most in the balance sheet and the result, why the result rose or fell, and where the money went.
FAJJ Med
Largest movements
- Intangible fixed assets -€49,000
down €49,000 (-11.1%), from €441,000 to €392,000
- Cash +€30,362
up €30,362 (+231%), from €13,139 to €43,501
mainly Net result for the year (+€92,408) and Depreciation (+€49,537)
- Receivables within one year -€18,998
down €18,998 (-87.7%), from €21,663 to €2,666
of which Other amounts receivable: -€19,013
- Other debts -€128,859
down €128,859 (-36.9%), from €349,155 to €220,296
- Profit (loss) carried forward +€92,408
up €92,408 (+98.6%), from €93,729 to €186,137
No income-statement line moved by more than 1% of the activity.
From the 2024 result to the 2025 result
Each bar is the change in one income-statement line, as its effect on the result: higher costs pull it down, higher income lifts it.
Derived cash bridge
Derived from the 2024 and 2025 balance sheets and the 2025 result: not a filed cash-flow statement. It shows where the money came from and went.
Every line side by side
| Line | Code | 2024 | 2025 | Change | % |
|---|---|---|---|---|---|
| Total assets | 20/58 | €481,851 | €443,883 | -€37,968 | -7.9% |
| Fixed assets | 21/28 | €443,550 | €394,012 | -€49,537 | -11.2% |
| Intangible fixed assets | 21 | €441,000 | €392,000 | -€49,000 | -11.1% |
| Tangible fixed assets | 22/27 | €2,550 | €2,012 | -€537 | -21.1% |
| Furniture and vehicles | 24 | €2,550 | €2,012 | -€537 | -21.1% |
| Current assets | 29/58 | €38,301 | €49,870 | +€11,569 | +30.2% |
| Amounts receivable within one year | 40/41 | €21,663 | €2,666 | -€18,998 | -87.7% |
| Trade receivables | 40 | €1,289 | €1,305 | +€16 | +1.2% |
| Other amounts receivable | 41 | €20,374 | €1,361 | -€19,013 | -93.3% |
| Cash at bank and in hand | 54/58 | €13,139 | €43,501 | +€30,362 | +231% |
| Deferred charges and accrued income | 490/1 | €3,499 | €3,704 | +€204 | +5.8% |
| Total equity and liabilities | 10/49 | €481,851 | €443,883 | -€37,968 | -7.9% |
| Equity | 10/15 | €98,729 | €191,137 | +€92,408 | +93.6% |
| Contributions | 10/11 | €5,000 | €5,000 | = | 0.0% |
| Profit (loss) carried forward | 14 | €93,729 | €186,137 | +€92,408 | +98.6% |
| Amounts payable | 17/49 | €383,122 | €252,746 | -€130,376 | -34.0% |
| Amounts payable within one year | 42/48 | €383,122 | €252,746 | -€130,376 | -34.0% |
| Trade debts | 44 | €866 | €41 | -€825 | -95.3% |
| Suppliers | 440/4 | €866 | €41 | -€825 | -95.3% |
| Taxes, remuneration and social security | 45 | €33,101 | €32,409 | -€693 | -2.1% |
| Taxes | 450/3 | €33,101 | €32,409 | -€693 | -2.1% |
| Other amounts payable | 47/48 | €349,155 | €220,296 | -€128,859 | -36.9% |
| Depreciation of and write-downs on formation expenses, intangible and tangible fixed assets | 630 | €49,137 | €49,537 | +€401 | +0.8% |
| Other operating charges | 640/8 | €437 | €400 | -€38 | -8.6% |
| Gross operating margin | 9900 | €183,302 | €183,061 | -€241 | -0.1% |
| Operating profit (loss) | 9901 | €133,728 | €133,124 | -€604 | -0.5% |
| Financial income | 75/76B | €113 | - | -€113 | |
| Recurring financial income | 75 | €113 | - | -€113 | |
| Financial charges | 65/66B | €7,010 | €8,307 | +€1,297 | +18.5% |
| Recurring financial charges | 65 | €7,010 | €8,307 | +€1,297 | +18.5% |
| Profit (loss) for the period before taxes | 9903 | €126,830 | €124,817 | -€2,014 | -1.6% |
| Income taxes | 67/77 | €33,101 | €32,409 | -€693 | -2.1% |
| Profit (loss) for the period | 9904 | €93,729 | €92,408 | -€1,321 | -1.4% |
| Profit (loss) for the period to be appropriated | 9905 | €93,729 | €92,408 | -€1,321 | -1.4% |
Source: filed annual accounts (NBB), financial years ended 31 December 2024 and 31 December 2025. Colour: green is a favourable move for that line, red an unfavourable one. Prepared on 23 October 2026 via checked.be.